SCOTT M ROCKLAGE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SCOTT M ROCKLAGE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SCOTT M ROCKLAGE. SCOTT M ROCKLAGE is Director in CUBIST PHARMACEUTICALS INC ($CBST) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in Pulmatrix, Inc. ($PULM) and Director in Cidara Therapeutics, Inc. ($CDTX) and in Aprea Therapeutics, Inc. ($APRE) and Director in Aprea Therapeutics, Inc. ($APRE).
Latest Insider Trading Transactions of SCOTT M ROCKLAGE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APRE, CDTX, CBST, CRXX, PULM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 01 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | A | 38.78 | 5,600 | 217,168 | 5,600 | ||
Jun 18 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 33.30 | 4,807 | 160,073 | 75,965 | 80.8 K to 76 K (-5.95 %) |
Jun 18 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 33.30 | 115,357 | 3,841,388 | 1,823,192 | 1.9 M to 1.8 M (-5.95 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 28.75 | 9,800 | 281,776 | 80,772 | 90.6 K to 80.8 K (-10.82 %) |
Jun 15 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 28.75 | 235,200 | 6,762,635 | 1,938,549 | 2.2 M to 1.9 M (-10.82 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 10,200 | 358,530 | 90,572 | 100.8 K to 90.6 K (-10.12 %) |
May 21 2020 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Director | Sell | S | 35.15 | 244,800 | 8,604,720 | 2,173,748 | 2.4 M to 2.2 M (-10.12 %) |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 20,519 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 492,475 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 79,746 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Option Exercise | C | 0.00 | 1,913,910 | 0 | 0 | ||
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 20,519 | 0 | 100,772 | 80.3 K to 100.8 K (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 492,475 | 0 | 2,418,548 | 1.9 M to 2.4 M (+25.57 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 79,746 | 0 | 80,253 | 507 to 80.3 K (+15,728.99 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | ROCKLAGE SCOTT M | Buy | C | 0.00 | 1,913,910 | 0 | 1,926,073 | 12.2 K to 1.9 M (+15,735.51 %) | |
Jun 15 2018 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
Jun 15 2018 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 5.30 | 11,000 | 58,300 | 11,000 | |
Jun 23 2017 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 6.90 | 11,000 | 75,900 | 11,000 | |
Jun 24 2016 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 10.22 | 9,000 | 91,980 | 9,000 | |
Feb 25 2016 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Option Exercise | A | 2.80 | 8,800 | 24,640 | 8,800 | |
Feb 25 2016 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Option Exercise | A | 2.80 | 8,800 | 24,640 | 8,800 | |
Jun 25 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Option Exercise | A | 11.00 | 1,108 | 12,188 | 1,108 | |
Jun 17 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Option Exercise | A | 11.80 | 17,710 | 208,978 | 17,710 | |
Jun 17 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Option Exercise | A | 7.56 | 52,784 | 399,179 | 52,784 | |
Jun 17 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Option Exercise | A | 7.56 | 372,606 | 2,817,833 | 372,606 | |
Jun 17 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Buy | P | 6.88 | 4,815 | 33,103 | 168,873 | 164.1 K to 168.9 K (+2.93 %) |
Jun 17 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Grant | A | 0.00 | 164,058 | 0 | 164,058 | 0 to 164.1 K |
Jun 17 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Buy | P | 6.88 | 33,990 | 233,681 | 1,192,154 | 1.2 M to 1.2 M (+2.93 %) |
Jun 17 2015 | PULM | Pulmatrix, Inc. | ROCKLAGE SCOTT M | Director | Grant | A | 0.00 | 1,158,164 | 0 | 1,158,164 | 0 to 1.2 M |
Jun 11 2015 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 15.91 | 9,000 | 143,190 | 9,000 | |
Jun 08 2015 | CRXX | EPIRUS Biopharmace ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 6.39 | 9,000 | 57,510 | 9,000 | |
Apr 22 2015 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | C | 0.00 | 45,467 | 0 | 0 | |
Apr 22 2015 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Option Exercise | C | 0.00 | 1,764,195 | 0 | 0 | |
Apr 22 2015 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Buy | C | 0.00 | 45,467 | 0 | 50,412 | 4.9 K to 50.4 K (+919.45 %) |
Apr 22 2015 | CDTX | Cidara Therapeutic ... | ROCKLAGE SCOTT M | Director | Buy | C | 0.00 | 1,764,195 | 0 | 1,956,099 | 191.9 K to 2 M (+919.31 %) |
Dec 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 11.92 | 1,000 | 11,921 | 166,448 | 167.4 K to 166.4 K (-0.60 %) |
Dec 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 11.80 | 4,000 | 47,200 | 167,448 | 171.4 K to 167.4 K (-2.33 %) |
Dec 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 12.00 | 4,500 | 54,000 | 171,448 | 175.9 K to 171.4 K (-2.56 %) |
Dec 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 12.00 | 500 | 6,001 | 175,948 | 176.4 K to 175.9 K (-0.28 %) |
Nov 23 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 12.00 | 5,000 | 60,000 | 176,448 | 181.4 K to 176.4 K (-2.76 %) |
Nov 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.14 | 1,000 | 10,140 | 181,448 | 182.4 K to 181.4 K (-0.55 %) |
Nov 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.18 | 2,000 | 20,360 | 182,448 | 184.4 K to 182.4 K (-1.08 %) |
Nov 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.20 | 1,700 | 17,340 | 184,448 | 186.1 K to 184.4 K (-0.91 %) |
Nov 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.22 | 300 | 3,066 | 186,148 | 186.4 K to 186.1 K (-0.16 %) |
Oct 05 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.23 | 287 | 2,936 | 186,448 | 186.7 K to 186.4 K (-0.15 %) |
Oct 05 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.22 | 732 | 7,481 | 186,735 | 187.5 K to 186.7 K (-0.39 %) |
Oct 05 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.21 | 981 | 10,016 | 187,467 | 188.4 K to 187.5 K (-0.52 %) |
Oct 05 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.15 | 2,500 | 25,375 | 188,448 | 190.9 K to 188.4 K (-1.31 %) |
Oct 05 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.15 | 500 | 5,076 | 190,948 | 191.4 K to 190.9 K (-0.26 %) |
Sep 30 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.00 | 5,000 | 50,000 | 191,448 | 196.4 K to 191.4 K (-2.55 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.45 | 1,000 | 10,450 | 196,448 | 197.4 K to 196.4 K (-0.51 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.35 | 1,000 | 10,350 | 197,448 | 198.4 K to 197.4 K (-0.50 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.32 | 1,000 | 10,320 | 198,448 | 199.4 K to 198.4 K (-0.50 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.31 | 2,000 | 20,620 | 199,448 | 201.4 K to 199.4 K (-0.99 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.45 | 1,000 | 10,450 | 196,448 | 197.4 K to 196.4 K (-0.51 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.35 | 1,000 | 10,350 | 197,448 | 198.4 K to 197.4 K (-0.50 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.32 | 1,000 | 10,320 | 198,448 | 199.4 K to 198.4 K (-0.50 %) |
Aug 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.31 | 2,000 | 20,620 | 199,448 | 201.4 K to 199.4 K (-0.99 %) |
Jul 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.99 | 968 | 10,638 | 201,448 | 202.4 K to 201.4 K (-0.48 %) |
Jul 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 11.05 | 2,503 | 27,658 | 202,416 | 204.9 K to 202.4 K (-1.22 %) |
Jul 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 11.06 | 100 | 1,106 | 204,919 | 205 K to 204.9 K (-0.05 %) |
Jul 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 11.07 | 300 | 3,321 | 205,019 | 205.3 K to 205 K (-0.15 %) |
Jul 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 11.09 | 1,100 | 12,199 | 205,319 | 206.4 K to 205.3 K (-0.53 %) |
Jul 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 11.12 | 29 | 322 | 206,419 | 206.4 K to 206.4 K (-0.01 %) |
Jun 14 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Option Exercise | A | 10.09 | 25,000 | 252,250 | 25,000 | |
Jun 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.00 | 1,592 | 15,920 | 206,448 | 208 K to 206.4 K (-0.77 %) |
Jun 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.04 | 1,300 | 13,052 | 208,040 | 209.3 K to 208 K (-0.62 %) |
Jun 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.14 | 2,108 | 21,375 | 209,340 | 211.4 K to 209.3 K (-1.00 %) |
May 03 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.00 | 5,000 | 50,000 | 211,448 | 216.4 K to 211.4 K (-2.31 %) |
Apr 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.00 | 5,000 | 50,000 | 216,448 | 221.4 K to 216.4 K (-2.26 %) |
Mar 18 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Option Exercise | M | 4.38 | 1,563 | 6,838 | 0 | |
Mar 18 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Option Exercise | M | 3.81 | 4,806 | 18,325 | 0 | |
Mar 18 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Option Exercise | M | 2.41 | 41,842 | 100,672 | 0 | |
Mar 18 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Buy | M | 4.38 | 1,563 | 6,838 | 221,448 | 219.9 K to 221.4 K (+0.71 %) |
Mar 18 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Buy | M | 3.81 | 4,806 | 18,325 | 219,885 | 215.1 K to 219.9 K (+2.23 %) |
Mar 18 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Buy | M | 2.41 | 41,842 | 100,672 | 215,079 | 173.2 K to 215.1 K (+24.15 %) |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Option Exercise | M | 2.41 | 24,167 | 58,242 | 73,991 | |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Buy | M | 2.41 | 24,167 | 58,242 | 173,237 | 149.1 K to 173.2 K (+16.21 %) |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | S | 10.40 | 1,500 | 15,600 | 149,070 | 150.6 K to 149.1 K (-1.00 %) |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | S | 10.40 | 1,500 | 15,602 | 150,570 | 152.1 K to 150.6 K (-0.99 %) |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | S | 10.44 | 1,000 | 10,440 | 152,070 | 153.1 K to 152.1 K (-0.65 %) |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | S | 10.44 | 2,000 | 20,882 | 153,070 | 155.1 K to 153.1 K (-1.29 %) |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | S | 10.50 | 9,100 | 95,550 | 155,070 | 164.2 K to 155.1 K (-5.54 %) |
Mar 15 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | S | 10.50 | 9,067 | 95,213 | 164,170 | 173.2 K to 164.2 K (-5.23 %) |
Mar 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.50 | 1,000 | 10,500 | 173,237 | 174.2 K to 173.2 K (-0.57 %) |
Mar 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.66 | 100 | 1,066 | 174,237 | 174.3 K to 174.2 K (-0.06 %) |
Mar 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.65 | 1,700 | 18,105 | 174,337 | 176 K to 174.3 K (-0.97 %) |
Mar 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.64 | 200 | 2,128 | 176,037 | 176.2 K to 176 K (-0.11 %) |
Mar 01 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 10.71 | 2,000 | 21,420 | 176,237 | 178.2 K to 176.2 K (-1.12 %) |
Feb 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 14.05 | 35 | 492 | 178,237 | 178.3 K to 178.2 K (-0.02 %) |
Feb 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 14.04 | 2,900 | 40,716 | 178,272 | 181.2 K to 178.3 K (-1.60 %) |
Feb 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 14.06 | 100 | 1,406 | 181,172 | 181.3 K to 181.2 K (-0.06 %) |
Feb 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 14.01 | 2,700 | 37,827 | 181,272 | 184 K to 181.3 K (-1.47 %) |
Feb 02 2004 | CBST | CUBIST PHARMACEUTI ... | ROCKLAGE SCOTT M | Director | Sell | D | 14.00 | 4,265 | 59,710 | 183,972 | 188.2 K to 184 K (-2.27 %) |
Page: 1